Pakistan healthcare market: size, growth and outlook 2026–2032

A 240-million-person market with low bed density and growing private chains. Published estimates normalised to 2025 range from USD 12.2 bn to USD 12.2 bn; the Consulting Wallah central estimate is USD 6.5 bn, growing at about 8% a year to USD 11.1 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.

Growth is driven by population ~245 mn growing 1.7% a year with low bed density (~0.7 per 1,000) creating structural under-capacity; private hospital revenue growth ~29% YoY FY25 as patients shift from overloaded public system; rising clinic fees and HHSA nominal output +19.9% (FY25).

Context that matters for buyers and suppliers: Pakistan had 1,696 hospitals and 167,947 beds in CY23-24, up from 1,284 hospitals and 151,661 beds in CY22. Health expenditure was 0.9% of GDP in FY24 versus 1.4% in CY22; South Asia average ~3.3%. Private hospital sample: gross margin 22.3%, operating margin 13.1%, net margin 6.8% in FY25. Lahore district has 4,342 registered private hospitals with 20,826 beds vs 50 government hospitals with 13,634 beds.

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 12.2 bn–USD 12.2 bn; differences are mostly scope.

Included: public and private hospital, clinic, diagnostic and long-term care services and the associated health expenditure. Excluded: pharmaceutical and device product sales, insurance premiums and health IT (covered in separate reports). Published totals differ mainly by whether products and insurance are folded in.

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• Pakistan had 1,696 hospitals and 167,947 beds in CY23-24, up from 1,284 hospitals and 151,661 beds in CY22 (PACRA)
• Health expenditure was 0.9% of GDP in FY24 versus 1.4% in CY22; South Asia average ~3.3% (PACRA)
• Private hospital sample: gross margin 22.3%, operating margin 13.1%, net margin 6.8% in FY25 (PACRA)
• Lahore district has 4,342 registered private hospitals with 20,826 beds vs 50 government hospitals with 13,634 beds (EUAA)
• Punjab public hospital admissions were 6.05 mn in FY2023-24 (Lahore 1.07 mn) (EUAA)
• Indus University Hospital will be Pakistan's largest free-of-cost hospital at 1,350 beds; Sindh grant to IHHN rose from Rs 300 mn to Rs 8 bn a year (Business Recorder)
• Inpatient care is 34.0% of the healthcare providers market (MarketLine, 2024) (MarketLine)
• Government health expenditure ~USD 3.2 bn in FY2024 (US ITA)

Where the GCC and India sit

• Hospitals / beds (national): 1,934 hospitals; 173,971 beds; 1,328 population per bed; 6,239 dispensaries; 5,746 BHUs; 802 RHCs (2025 (P)) — Pakistan Economic Survey 2025-26
• Bed density: ~0.7 beds per 1,000 (CY24) vs India ~1.6, Bangladesh ~1.0, Sri Lanka ~3.9 (CY20) (2024) — PACRA
• Workforce: 336,582 registered doctors; 42,118 dentists; 138,391 nurses; ~1.3 doctors per 1,000 (2025 (P)) — Pakistan Economic Survey 2025-26; PACRA
• Health spend per capita: USD ~30.5 current health expenditure per capita (CY23); health spend ~0.9% GDP vs South Asia avg ~3.3% (2023) — PACRA
• Lahore district: 50 govt hospitals (13,634 beds) vs 4,342 private hospitals (20,826 beds); 954 people per bed (2023) — EUAA (Punjab Health Statistics 2024)
• Population: ~245 mn (1.7% growth); UHC index 53.9 (CY23) (2024) — PACRA

Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation

Opportunities we see: medical devices market ~USD 700 mn growing 12-15% (monitors, ventilators, imaging, dialysis, refurbished equipment); new private hospital construction and diagnostic/dialysis centre expansion in Tier-2 cities; health IT, telemedicine and eHealth.

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Operators and investors: capacity, payer rules and licensing timelines decide returns; design central procurement and insurer contracting into the operating model before opening.
• Suppliers: registration, a local partner and payer-formulary presence are the gates; central tenders reward structured quotations and reliable supply over the lowest price.
• Hospital leaders: payer pressure makes the 25–35% of cost in supplies the margin lever — see the free executive assessment.

1. PACRA, PACRA Research - Healthcare - Feb 2026 — pacra.com
2. Ministry of Finance, Pakistan, Pakistan Economic Survey 2025-26, Chapter 11 Health and Nutrition — finance.gov.pk
3. US International Trade Administration, Pakistan - Healthcare and Medical Equipment (Country Commercial Guide) — trade.gov
4. MarketLine, Healthcare Providers in Pakistan — marketresearch.com
5. EUAA, Pakistan Country Focus - Healthcare (Lahore) — euaa.europa.eu
6. Business Recorder, Bilawal inaugurates Rs72 billion Indus University Hospital project — brecorder.com
7. MarketLine (via MarketResearch.com) (2025) — USD 11.6 'million' as printed (likely bn; inpatient care USD 4.0 'million' = 34.0%) (2024) to — (2029), CAGR 5.0% (2019-2024); scope: country - Pakistan healthcare providers market (inpatient, outpatient, long-term care, medical goods, collective services); units on public page appear misprinted — source
8. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
9. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.